NXEN (Nexien BioPharma) FCF Margin %: 0.00% (As of Mar. 2025)


What is Nexien BioPharma FCF Margin %?

Nexien BioPharma NXEN FCF Margin % is 0.00% as of Mar. 2025.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nexien BioPharma's Free Cash Flow for the three months ended in Mar. 2025 was $-0.01 Mil. Nexien BioPharma's Revenue for the three months ended in Mar. 2025 was $0.00 Mil. Therefore, Nexien BioPharma's FCF Margin % for the quarter that ended in Mar. 2025 was 0.00%.

As of today, Nexien BioPharma's current FCF Yield % is 0.00%.

The historical rank and industry rank for Nexien BioPharma's FCF Margin % or its related term are showing as below:


NXEN's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.48
* Ranked among companies with meaningful FCF Margin % only.

Nexien BioPharma FCF Margin % Related Terms

Nexien BioPharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Nexien BioPharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexien BioPharma FCF Margin % Chart

Nexien BioPharma Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nexien BioPharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NXEN vs FLHLF, ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nexien BioPharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nexien BioPharma FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nexien BioPharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nexien BioPharma's FCF Margin % falls into.


Nexien BioPharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nexien BioPharma's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=-0.064/0
= %

Nexien BioPharma's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-0.013/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Nexien BioPharma (NXEN) has a FCF Margin % of 0.00% as of Mar. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nexien BioPharma and its competitors.
Is Nexien BioPharma's FCF Margin % too high?
Nexien BioPharma's current FCF Margin % is 0.00%.
How does Nexien BioPharma's FCF Margin % compare to FLHLF and ZTS?
Nexien BioPharma's FCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nexien BioPharma and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexien BioPharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexien BioPharma stock overvalued right now?
Nexien BioPharma (NXEN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Nexien BioPharma (NXEN), the current FCF Margin % is 0.00% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexien BioPharma Business Description

Address 4340 East Kentucky Avenue, Suite 206, Glendale, CO, USA, 80246
Nexien BioPharma Inc is engaged in pre-clinical and drug development activities, by U.S. Food and Drug Administration (FDA) protocols, for certain pharmaceutical formulations that include cannabinoids. The company is pursuing the formulation and development of drugs containing cannabinoids for the treatment of various diseases, disorders, and medical conditions.